BARDA Funds HostDx Test Development
Inflammatix’s HostDx fever test reads the immune system to rapidly diagnose acute infections at the point of care.
Read More
Search Results for: point-of-care
Collaborators to Assess Developing Low-Cost POC Tests for Common STIs
SpeeDx and the QuantuMDx Group are collaborating with the Foundation for Innovative New Diagnostics to assess the feasibility of developing low-cost, point-of-care tests for common sexually transmitted infections.
Read More
Navify Guidelines App Offers Clinicians Guidance for Patients with Common Cancers
The Navify guidelines app pulls the latest clinical guidance for breast, colorectal, non-small cell lung, and prostate cancers from the National Comprehensive Cancer Network.
Read More
ProciseDx Plans Additional Financing in Q1 2020
The company will use the funds to develop and market near-patient, 2- to 5-minute tests to detect and monitor biomarkers for inflammatory and autoimmune diseases and for metabolic syndromes.
Read More
UK Trial to Evaluate POC Test for Early Detection of Sepsis
To detect emergent sepsis, the study aims to develop a rapid diagnostic based on multiple biomarkers.
Read More